Search Results 241-250 of 17406 for methyldopa

  1. A Study to Assess Metformin Hydrochloride in Patients With Atypical Hyperplasia or In Situ Breast Cancer to Placebo in Decreasing Atypical Cells in Patients With Atypical Hyperplasia or in Situ Breast Cancer - Mayo Clinic

    Note: The standard drug used for the "breast cancer prevention" is tamoxifen. If the patient is eligible to take tamoxifen, he/she must be offered tamoxifen ...

  2. Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects - Mayo Clinic

    About this study. To assess if oral nizatidine or lisinopril alone and in combination will increase heme oxygenase 1 (HO-1) protein concentration and ...

  3. Intensity-modulated radiation therapy (IMRT) - Doctors & Departments - Mayo Clinic

    Learn how technology allows specialists to precisely manipulate radiation therapy beams so that they conform to the shape of a tumor and avoid healthy ...

  4. A Phase 1/2a Dose-Finding Study Of PT-112 In Patients With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

    Study PT-112-102, a multicenter, open-label dose-finding and pharmacokinetic study of PT-112 in patients with relapsed or refractory multiple myeloma. This is ...

  5. Study Of DFMO Plus Retifanlimab For High-grade Glioma - Mayo Clinic

    About this study. This is an early phase study of difluoromethylornithine (DFMO) in combination with an immune checkpoint inhibitor (ICI) called ...

  6. Filgotinib In Long-Term Extension Study Of Adults With Crohn's Disease - Mayo Clinic

    The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy ...

  7. A Study Of The Safety And Effectiveness Of NEOD001 For Treating Previously Treated Patients With Persistent Cardiac Dysfunction Related To Light Chain Amyloidosis - Mayo Clinic

    A Study Of The Safety And Effectiveness Of NEOD001 For Treating Previously Treated Patients With Persistent Cardiac Dysfunction Related To Light Chain ...

  8. A Phase 1b/2 Safety And Tolerability Of MEDI6469 In Combination With Therapeutic Immune Agents Or Monoclonal Antibodies - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Endocrinology - Doctors - Mayo Clinic

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  10. Efficacy, Safety, Tolerability, Pharmacodynamics, And Pharmacokinetics Of BIA 28-6156 In GBA-PD - Mayo Clinic

    ... methyldopa, tetrabenazine, deutetrabenazine, valbenazine, or reserpine. The subject has received a vaccination within 14 days before administration of the ...